Abstract

Many human melanoma tumors express antigens that are recognized in vitro by cytolytic T lymphocytes (CTLs) derived from the tumor-bearing patient. A gene was identified that directed the expression of antigen MZ2-E on a human melanoma cell line. This gene shows no similarity to known sequences and belongs to a family of at least three genes. It is expressed by the original melanoma cells, other melanoma cell lines, and by some tumor cells of other histological types. No expression was observed in a panel of normal tissues. Antigen MZ2-E appears to be presented by HLA-A1; anti-MZ2-E CTLs of the original patient recognized two melanoma cell lines of other HLA-A1 patients that expressed the gene. Thus, precisely targeted immunotherapy directed against antigen MZ2-E could be provided to individuals identified by HLA typing and analysis of the RNA of a small tumor sample.

Keywords

MelanomaHuman leukocyte antigenAntigenCytolysisGeneImmunotherapyBiologyCytotoxic T cellImmunologyCancer researchIn vitroImmune systemGenetics

Affiliated Institutions

Related Publications

Publication Info

Year
1991
Type
article
Volume
254
Issue
5038
Pages
1643-1647
Citations
3497
Access
Closed

External Links

View on DOI.org

Social Impact

Altmetric
PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

3497
OpenAlex

Cite This

Pierre van der Bruggen, Catia Traversari, Patrick Chomez et al. (1991). A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma. Science , 254 (5038) , 1643-1647. https://doi.org/10.1126/science.1840703

Identifiers

DOI
10.1126/science.1840703